MX2008000291A - Preparacion de conjugados polimericos de compuestos de aditivos terapeuticos, agricolas y alimentarios. - Google Patents

Preparacion de conjugados polimericos de compuestos de aditivos terapeuticos, agricolas y alimentarios.

Info

Publication number
MX2008000291A
MX2008000291A MX2008000291A MX2008000291A MX2008000291A MX 2008000291 A MX2008000291 A MX 2008000291A MX 2008000291 A MX2008000291 A MX 2008000291A MX 2008000291 A MX2008000291 A MX 2008000291A MX 2008000291 A MX2008000291 A MX 2008000291A
Authority
MX
Mexico
Prior art keywords
agricultural
therapeutic
food additive
additive compounds
polymer conjugates
Prior art date
Application number
MX2008000291A
Other languages
English (en)
Inventor
Andrei W Konradi
Christopher M Semko
Jenifer L Smith
Michael S Dappen
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of MX2008000291A publication Critical patent/MX2008000291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invencion describe un proceso para preparar conjugados polimericos de compuestos agricolas, terapeuticos y aditivos alimentarios usando las afecciones de Mitsunobu.
MX2008000291A 2005-07-08 2006-07-07 Preparacion de conjugados polimericos de compuestos de aditivos terapeuticos, agricolas y alimentarios. MX2008000291A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69772605P 2005-07-08 2005-07-08
PCT/US2006/026292 WO2007008563A2 (en) 2005-07-08 2006-07-07 Preparation of pegylated conjugates of vla-4 antagonists via a mitsunobu' s reaction

Publications (1)

Publication Number Publication Date
MX2008000291A true MX2008000291A (es) 2008-04-04

Family

ID=37038371

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008000291A MX2008000291A (es) 2005-07-08 2006-07-07 Preparacion de conjugados polimericos de compuestos de aditivos terapeuticos, agricolas y alimentarios.

Country Status (14)

Country Link
US (3) US8268935B2 (es)
EP (1) EP1901778A2 (es)
JP (1) JP2009501246A (es)
KR (1) KR20080031053A (es)
CN (1) CN101505800A (es)
AU (1) AU2006269382B2 (es)
BR (1) BRPI0612407A2 (es)
CA (1) CA2614200A1 (es)
IL (1) IL188194A (es)
MX (1) MX2008000291A (es)
NZ (1) NZ564836A (es)
SG (2) SG196786A1 (es)
WO (1) WO2007008563A2 (es)
ZA (1) ZA200711116B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706399A1 (en) * 2004-01-23 2006-10-04 Elan Pharmaceuticals, Inc. Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
KR101273614B1 (ko) * 2004-07-08 2013-06-12 엘란 파마슈티칼스, 인크. 중합체 부분을 포함하는 다가 ｖｌａ―４ 길항제
KR20080031053A (ko) * 2005-07-08 2008-04-07 엘란 파마슈티칼스, 인크. 치료, 농업 및 식품 첨가제 화합물의 중합체 컨쥬게이트의제조 방법
AU2007253717A1 (en) 2006-05-22 2007-11-29 Elan Pharmaceuticals, Inc. Preparation of polymer conjugates of therapeutic, agricultural and food additive compounds
EP2231185A4 (en) * 2007-12-07 2012-06-27 Elan Pharm Inc METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
AU2011245140A1 (en) * 2010-04-30 2012-12-20 Elan Pharmaceuticals, Inc. Selective integrin inhibitors
US8864892B2 (en) 2012-06-21 2014-10-21 Empire Technology Development Llc Tailorable lignosulfonate carbonate adhesives
JP6343600B2 (ja) 2013-02-28 2018-06-13 武田薬品工業株式会社 スルホニルクロライド化合物の製造法
JP2024505002A (ja) * 2021-01-27 2024-02-02 ユニバーシティ オブ カンザス インスリン結合性ｂ細胞においてアネルギーを誘導するための抑制受容体リガンドとのコンジュゲート

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
EP0330506A3 (en) 1988-02-26 1990-06-20 Dana Farber Cancer Institute Vla proteins
US5177059A (en) 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates
US5824701A (en) 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5510332A (en) 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
DE69530392D1 (de) 1994-07-11 2003-05-22 Athena Neurosciences Inc Inhibitoren der leukozytenadhäsion
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1061954B1 (en) 1998-03-12 2004-06-09 Nektar Therapeutics Al, Corporation Poly(ethylene glycol) derivatives with proximal reactive groups
US6479492B1 (en) 1999-01-22 2002-11-12 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1253923A1 (en) 2000-01-28 2002-11-06 Biogen, Inc. Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
AU2001257577A1 (en) * 2000-02-28 2001-09-03 Shearwater Corporation Water-soluble polymer conjugates of artelinic acid
US20040043030A1 (en) 2001-07-31 2004-03-04 Immunomedics, Inc. Polymeric delivery systems
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
PL213322B1 (pl) * 2002-01-18 2013-02-28 Biogen Idec Inc Kompozycja farmaceutyczna zawierajaca polimer glikolu polialkilenowego skoniugowany z biologicznie aktywnym zwiazkiem lub jego prekursorem oraz jej zastosowania
ES2544527T3 (es) * 2002-07-31 2015-09-01 Seattle Genetics, Inc. Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
US20050074451A1 (en) * 2003-06-25 2005-04-07 Elan Pharmaceuticals, Inc. Methods and compositions for treating rheumatoid arthritis
EP1706399A1 (en) 2004-01-23 2006-10-04 Elan Pharmaceuticals, Inc. Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
WO2005111020A2 (en) * 2004-04-30 2005-11-24 Elan Pharmaceuticals, Inc. Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4
KR101273614B1 (ko) * 2004-07-08 2013-06-12 엘란 파마슈티칼스, 인크. 중합체 부분을 포함하는 다가 ｖｌａ―４ 길항제
KR20080031053A (ko) * 2005-07-08 2008-04-07 엘란 파마슈티칼스, 인크. 치료, 농업 및 식품 첨가제 화합물의 중합체 컨쥬게이트의제조 방법
EP2231185A4 (en) * 2007-12-07 2012-06-27 Elan Pharm Inc METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS

Also Published As

Publication number Publication date
US20140073788A1 (en) 2014-03-13
US8569426B2 (en) 2013-10-29
CA2614200A1 (en) 2007-01-18
US8268935B2 (en) 2012-09-18
IL188194A0 (en) 2008-03-20
SG196786A1 (en) 2014-02-13
EP1901778A2 (en) 2008-03-26
CN101505800A (zh) 2009-08-12
JP2009501246A (ja) 2009-01-15
WO2007008563A2 (en) 2007-01-18
KR20080031053A (ko) 2008-04-07
SG163565A1 (en) 2010-08-30
BRPI0612407A2 (pt) 2010-11-03
US20070021555A1 (en) 2007-01-25
AU2006269382A1 (en) 2007-01-18
IL188194A (en) 2013-03-24
ZA200711116B (en) 2008-09-25
WO2007008563A3 (en) 2008-07-31
US20130018187A1 (en) 2013-01-17
AU2006269382B2 (en) 2014-01-16
NZ564836A (en) 2011-10-28

Similar Documents

Publication Publication Date Title
WO2007008560A3 (en) Stabilized edible foams
MX2008000291A (es) Preparacion de conjugados polimericos de compuestos de aditivos terapeuticos, agricolas y alimentarios.
MY140272A (en) Method and apparatus for consumable powder reconstitution and frothing
TW200628075A (en) Dairy product and process
WO2009001786A1 (ja) 生理活性物質含有組成物
PL1701701T5 (pl) Sposoby otrzymywania pianki zawierającej środek sklerotyzujący
SG160378A1 (en) Extruded solid product for use in foodstuffs
MY143805A (en) System and device for preparing and delivering food products from a mixture made up of a food liquid and a diluent
WO2006099013A3 (en) Concentrated liquid human milk fortifier (hmf)
MY181785A (en) Product containing epichlorohydrin, its preparation and its use in various applications
ATE460102T1 (de) Verfahren und vorrichtung zur zubereitung von getränken aus löslichen produkten
TW200513220A (en) Method and apparatus for preparing a food product
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
WO2009001787A1 (ja) 補酵素ｑ１０含有組成物
ZA201102693B (en) Enhanced beer foaming
RU2010104992A (ru) Пены для пищевых продуктов и напитков
WO2015070263A3 (en) Apparatus for foaming a liquid milk composition
JP2014217282A (ja) 炭酸ガス含有非アルコール飲料用起泡剤
CN102726527A (zh) 可发泡的乳组合物
MX2019010205A (es) Productos de confiteria libres de gelatina aireados, composiciones de estructuracion de espuma y metodos para preparar los mismos.
JP2013135659A (ja) ノンガスフォーマー容器詰め食品
CN103099280A (zh) 一种蜂蜜醋饮料的制作方法
TW499296B (en) Milk beverages composition
Borja et al. Functional properties of flours prepared from glucosinolate-rich vegetables: Alugbati (Basella rubra)
Klindukhov et al. Functional drinks for school children based on plant phospholipids

Legal Events

Date Code Title Description
FG Grant or registration